脑膜瘤癫痫发作的临床与基因组相关因素
多因素分析显示水肿和非典型组织学是术前癫痫的独立预测因素,NF2突变的影响通过非典型组织学和水肿间接介导;术后癫痫的预测因素包括术前癫痫、肿瘤复发和术后放疗。
要点
- 术后癫痫的独立预测因素为术前癫痫、肿瘤复发和需要术后放疗。
- 83.3%患者实现癫痫无发作,但仅20.8%的无发作患者能停用抗癫痫药物,且与全切除相关。
核心结论
- 脑膜瘤患者术前癫痫较常见,NF2突变与术前癫痫的关联通过水肿和非典型组织学介导。
- 术前癫痫可能提示更具侵袭性的分子特征和更高的复发风险。
- 术后癫痫风险与术前癫痫、肿瘤复发和术后放疗相关,与切除程度无关。
研究设计与样本
- 回顾性队列研究,纳入394例在耶鲁纽黑文医院接受手术的脑膜瘤患者,分析临床、组织学和基因组变量与术前及术后癫痫的相关性。
- 使用逻辑回归模型评估术前和术后癫痫的多重风险因素,并进行中介分析探究基因组亚组与癫痫之间的因果路径。
主要发现
- 单因素分析中,术前癫痫与体细胞NF2突变(p=0.020)、WHO II或III级肿瘤(p=0.029)、非典型组织学(p=0.004)、水肿(p<0.001)、脑侵犯(p=0.009)及更差的无进展生存期(HR 2.68,95%CI 1.30-5.50)相关。
- 多因素分析中,水肿(OR 3.11,95%CI 1.46-6.65,p=0.003)和非典型组织学(OR 2.00,95%CI 1.03-3.90,p=0.041)是术前癫痫的独立预测因素,基因组亚组不是独立预测因素;NF2突变的影响通过非典型组织学和水肿间接介导(p=0.012)。
- 83.3%的患者实现癫痫无发作,仅20.8%的无发作患者术后能停用抗癫痫药物,且这些患者更可能接受全切除(p=0.031)。
- 多因素分析中,术前癫痫(OR 3.54,95%CI 1.37-9.12,p=0.009)、复发肿瘤(OR 2.89,95%CI 1.08-7.74,p=0.035)和需要术后放疗(OR 2.82,95%CI 1.09-7.33,p=0.033)是术后癫痫的显著预测因素。
临床怎么用
- 对于脑膜瘤患者,应评估术前癫痫风险,尤其关注存在水肿或非典型组织学的患者。
- 术后癫痫高危患者(术前癫痫、肿瘤复发、接受术后放疗)需加强监测和抗癫痫管理。
- 即使实现癫痫无发作,多数患者仍难以停用抗癫痫药物,停药决策需谨慎并结合切除程度等因素。
局限性
- 回顾性单中心研究,样本量394例,可能存在选择偏倚。
- 基因组测序数据的具体范围和方法未在摘要中详述。
- 癫痫无发作和停药的相关因素分析为观察性结果,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The association of seizures with meningiomas is poorly understood. Moreover, any relationship between seizures and the underlying meningioma genomic subgroup has not been studied. Herein, the authors report on their experience with identifying clinical and genomic factors associated with preoperative and postoperative seizure presentation in meningioma patients. METHODS: Clinical and genomic sequencing data on 394 patients surgically treated for meningioma at Yale New Haven Hospital were reviewed. Correlations between clinical, histological, or genomic variables and the occurrence of preoperative and postoperative seizures were analyzed. Logistic regression models were developed for assessing multiple risk factors for pre- and postoperative seizures. Mediation analyses were also conducted to investigate the causal pathways between genomic subgroups and seizures. RESULTS: Seventeen percent of the cohort had presented with preoperative seizures. In a univariate analysis, patients with preoperative seizures were more likely to have tumors with a somatic NF2 mutation (p = 0.020), WHO grade II or III tumor (p = 0.029), atypical histology (p = 0.004), edema (p < 0.001), brain invasion (p = 0.009), and worse progression-free survival (HR 2.68, 95% CI 1.30-5.50). In a multivariate analysis, edema (OR 3.11, 95% CI 1.46-6.65, p = 0.003) and atypical histology (OR 2.00, 95% CI 1.03-3.90, p = 0.041) were positive predictors of preoperative seizures, while genomic subgroup was not, such that the effect of an NF2 mutation was indirectly mediated through atypical histology and edema (p = 0.012). Seizure freedom was achieved in 83.3% of the cohort, and only 20.8% of the seizure-free patients, who were more likely to have undergone gross-total resection (p = 0.031), were able to discontinue antiepileptic drug use postoperatively. Preoperative seizures (OR 3.54, 95% CI 1.37-9.12, p = 0.009), recurrent tumors (OR 2.89, 95% CI 1.08-7.74, p = 0.035), and tumors requiring postoperative radiation (OR 2.82, 95% CI 1.09-7.33, p = 0.033) were significant predictors of postoperative seizures in a multivariate analysis. CONCLUSIONS: Seizures are relatively common at meningioma presentation. While NF2-mutated tumors are significantly associated with preoperative seizures, the association appears to be mediated through edema and atypical histology. Patients who undergo radiation and/or have a recurrence are at risk for postoperative seizures, regardless of the extent of resection. Preoperative seizures may indeed portend a more potentially aggressive molecular entity and challenging clinical course with a higher risk of recurrence.
引用
- Gupte TP, Li C, Jin L, et al. Clinical and genomic factors associated with seizures in meningiomas. J Neurosurg. 2020. PMID: 33276341. doi:10.3171/2020.7.JNS201042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。